Paul Welsh

Paul Welsh

University of Glasgow

H-index: 77

Europe-United Kingdom

About Paul Welsh

Paul Welsh, With an exceptional h-index of 77 and a recent h-index of 61 (since 2020), a distinguished researcher at University of Glasgow, specializes in the field of Epidemiology, biomarkers, CVD, diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

12 Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19

Twenty-four-hour ambulatory, but not clinic blood pressure associates with leptin in young adults with overweight or obesity: The African-PREDICT study

Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization

Epigenetic contributions to clinical risk prediction of cardiovascular disease

5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study

GDF15 linked to maternal risk of nausea and vomiting during pregnancy

Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes

Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes

Paul Welsh Information

University

Position

___

Citations(all)

25636

Citations(since 2020)

16502

Cited By

14614

hIndex(all)

77

hIndex(since 2020)

61

i10Index(all)

230

i10Index(since 2020)

206

Email

University Profile Page

University of Glasgow

Google Scholar

View Google Scholar Profile

Paul Welsh Skills & Research Interests

Epidemiology

biomarkers

CVD

diabetes

Top articles of Paul Welsh

Title

Journal

Author(s)

Publication Date

12 Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19

Robert A Sykes

Andrew J Morrow

Alex McConnachie

Anna Kamdar

Catherine Bagot

...

2024/3/1

Twenty-four-hour ambulatory, but not clinic blood pressure associates with leptin in young adults with overweight or obesity: The African-PREDICT study

Hypertension Research

Elandi van Niekerk

Botha-Le Roux

Catharina Mels

Mariette Swanepoel

Christian Delles

...

2024/2

Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization

Communications Medicine

Andrew J Morrow

Robert Sykes

Merna Saleh

Baryab Zahra

Alasdair MacIntosh

...

2024/2/28

Epigenetic contributions to clinical risk prediction of cardiovascular disease

Circulation: Genomic and Precision Medicine

Aleksandra D Chybowska

Danni A Gadd

Yipeng Cheng

Elena Bernabeu

Archie Campbell

...

2024/2

5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study

The Lancet Diabetes & Endocrinology

Michael EJ Lean

Wilma S Leslie

Alison C Barnes

Naomi Brosnahan

George Thom

...

2024/2/26

GDF15 linked to maternal risk of nausea and vomiting during pregnancy

Nature

M Fejzo

N Rocha

I Cimino

SM Lockhart

CJ Petry

...

2024/1/25

Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes

EBioMedicine

Caroline J Bull

Emma Hazelwood

Danny N Legge

Laura J Corbin

Tom G Richardson

...

2024/2/1

Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes

European Journal of Heart Failure

Kirsty McDowell

Carly Adamson

Colette Jackson

Ross Campbell

Paul Welsh

...

2024/1

Elevated lipoprotein (a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from …

Atherosclerosis

Paul Welsh

Anas Al Zabiby

Hannah Byrne

Harriet R Benbow

Taha Itani

...

2024/2/1

Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design

ESC Heart Failure

Jaclyn Carberry

Mark C Petrie

Matthew MY Lee

Katriona Brooksbank

Ross T Campbell

...

2024/4/12

The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)

Diabetologia

Laura J Corbin

David A Hughes

Caroline J Bull

Emma E Vincent

Madeleine L Smith

...

2024/1

Multiple cardiac biomarkers to improve prediction of cardiovascular events: findings from the Generation Scotland Scottish Family Health Study

Clinical Chemistry

Paul Welsh

Dorien M Kimenai

Anoop SV Shah

Danni A Gadd

Riccardo E Marioni

...

2024/2

Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study

British Journal of General Practice

Michael K Sullivan

Bhautesh Dinesh Jani

Elaine Rutherford

Paul Welsh

Alex McConnachie

...

2023/2/1

Blood-based epigenome–wide analyses of chronic low–grade inflammation across diverse population cohorts

medRxiv

Robert F Hillary

Hong Kiat Ng

Daniel L McCartney

Hannah R Elliott

Rosie M Walker

...

2023

Growth Differentiation Factor-15, Clinical Outcomes, and the Effect of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the DAPA-HF Trial

Journal of the American College of Cardiology

David Berg

Kieran F Docherty

Atefeh Talebi

Naveed Sattar

Petr Jarolim

...

2023/3/7

Association between walking pace and incident type 2 diabetes by adiposity level: A prospective cohort study from the UK Biobank

Diabetes, Obesity and Metabolism

Jirapitcha Boonpor

Solange Parra‐Soto

Jasunella Gore

Atefeh Talebi

Nathan Lynskey

...

2023/7

Carbohydrate antigen 125 in HFrEF and the effect of dapagliflozin: findings from DAPA-HF

Journal of the American College of Cardiology

Kieran F Docherty

Kirsty McDowell

Paul Welsh

Joanna Osmanska

Inder Anand

...

2023/5/2

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics

European Heart Journal

Su Ern Yeoh

Joanna Osmanska

Mark C Petrie

Katriona JM Brooksbank

Andrew L Clark

...

2023/8/14

Prediction of cardiometabolic health through changes in plasma proteins with intentional weight loss in the DiRECT and DIADEM-I randomized clinical trials of type 2 diabetes …

Diabetes care

Naveed Sattar

Shahrad Taheri

David P Astling

Jessica Chadwick

Michael A Hinterberg

...

2023/11/1

Precision Pharmacotherapy With Zibotentan in Microvascular Angina: a randomized, placebo-controlled, cross-over trial.

Colin Berry

Andrew Morrow

George Abraham

Stephen Hoole

John Greenwood

...

2023/12/21

See List of Professors in Paul Welsh University(University of Glasgow)